GDBspace, a Space Pharmaceuticals company, announces the beginning of a strategic collaboration with the University of Bern, Switzerland

GDBspace, a Space Pharmaceuticals company, is pleased to establish an annual collaboration with the University of Bern, Switzerland, embedded within the Department of Chemistry, Biochemistry & Pharmaceutical Sciences. The collaboration will capitalize on the world-class research environment in Bern, leveraging expertise and resources from both Space Pharmaceuticals and the University to drive innovation within AI-based drug discovery. By using GDBspace’s unique proprietary drug discovery engine, Space Peptides’ state-of-the-art peptide synthesis facilities and the University of Bern’s latest research development, the parties will stimulate and support innovative approaches to identify and develop AI-based therapeutics for the treatment of various diseases.